EUVIMEDEUVIMED entdecken
Crossref

EBV ‐ LMP1 Promotes the Progression of Nasopharyngeal Carcinoma via TNC ‐Mediated Activation of PI3K /Akt Pathway

Song Zhang iD, Jiahui Tang, Foliang Yuan, Hongyan Yuan, Shuxian Wu

The FASEB Journal · 31.12.2025 · 39 (24)

DOI: 10.1096/fj.202502319rr ↗

Kurz gefasst

Fachartikel in der Zeitschrift The FASEB Journal, erschienen am 31.12.2025. Verfasst von Song Zhang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otolaryngology, Shenzhen Guangming District People's Hospital, Shenzhen, China. Hauptthemen laut MEDLINE: Viral Matrix Proteins, Nasopharyngeal Carcinoma, Proto-Oncogene Proteins c-akt, Nasopharyngeal Neoplasms. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 26 Literaturangaben. Gefördert von: Shenzhen Municipal Science and Technology Innovation Council | Shenzhen Science and Technology Innovation Program, Shenzhen Science and Technology Innovation Program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Nasopharyngeal carcinoma (NPC) is the most prevalent malignant tumor within the field of otolaryngology and is strongly associated with Epstein–Barr virus (EBV) infection. Among the factors linked to NPC progression, EBV‐encoded LMP1 (latent membrane protein 1) serves as a primary contributor, although the underlying mechanisms remain partially understood. In this study, we employed a lentiviral system to establish a nasopharyngeal carcinoma cell line that stably expresses EBV‐LMP1, thereby simulating the LMP1‐positive nasopharyngeal carcinoma microenvironment. Our findings reveal that LMP1 upregulates the expression of TNC, which activates the PI3K‐Akt signaling pathway, ultimately facilitating the proliferation, survival, migration, and in vivo growth of nasopharyngeal carcinoma cells. Notably, the knockdown of TNC or inhibition of PI3K‐Akt signaling significantly reverses the enhancing effects of LMP1 on the malignant progression of NPC in both in vitro and in vivo contexts. Collectively, our results provide new insights into the mechanisms through which EBV‐LMP1 contributes to the malignant progression of NPC and suggest potential strategic targets and a scientific foundation for the treatment of EBV‐related NPC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Viral Matrix ProteinsNasopharyngeal CarcinomaProto-Oncogene Proteins c-aktNasopharyngeal NeoplasmsPhosphatidylinositol 3-KinasesHerpesvirus 4, HumanHumansSignal TransductionAnimalsMiceCell Line, TumorEpstein-Barr Virus InfectionsCell ProliferationDisease ProgressionMice, NudeCell MovementGene Expression Regulation, NeoplasticMice, Inbred BALB C

Stichwörter der Autor:innen

EBVLMP1NPCPI3K‐AktTNC

Substanzen

Viral Matrix ProteinsEBV-associated membrane antigen, Epstein-Barr virusProto-Oncogene Proteins c-aktPhosphatidylinositol 3-Kinases

Autor:innen und Institutionen

  • Department of Otolaryngology, Shenzhen Guangming District People's Hospital, Shenzhen, China.

ORCID-Profile: Song Zhang

Förderung

  • Shenzhen Municipal Science and Technology Innovation Council | Shenzhen Science and Technology Innovation Program
  • Shenzhen Science and Technology Innovation Program

Zitieren

APA

Zhang, S., Tang, J., Yuan, F., Yuan, H., & Wu, S. (2025). EBV ‐ LMP1 Promotes the Progression of Nasopharyngeal Carcinoma via TNC ‐Mediated Activation of PI3K /Akt Pathway. The FASEB Journal. https://doi.org/10.1096/fj.202502319rr

Vancouver

Zhang S, Tang J, Yuan F, Yuan H, Wu S. EBV ‐ LMP1 Promotes the Progression of Nasopharyngeal Carcinoma via TNC ‐Mediated Activation of PI3K /Akt Pathway. The FASEB Journal. 2025. doi:10.1096/fj.202502319rr

BibTeX
@article{Zhang2025,
  author = {Zhang, Song and Tang, Jiahui and Yuan, Foliang and Yuan, Hongyan and Wu, Shuxian},
  title = {EBV ‐ LMP1 Promotes the Progression of Nasopharyngeal Carcinoma via TNC ‐Mediated Activation of PI3K /Akt Pathway},
  journal = {The FASEB Journal},
  year = {2025},
  doi = {10.1096/fj.202502319rr}
}
Kostenlos starten →